Press release
Metabolic Testing Market Research Explores Growth Within A $0.91 Billion Opportunity
Metabolic Testing Market
Projected Expansion of the Metabolic Testing Market by 2030
The metabolic testing market is forecasted to expand significantly, reaching a valuation of $0.91 billion by 2030, with a compound annual growth rate (CAGR) of 7.3%. This growth is propelled by the rising popularity of personalized wellness programs, enhanced sports performance analytics, and an increasing need for remote health monitoring. Additionally, the broader adoption of wearable metabolic sensors and the integration of AI-driven diagnostic tools are notable contributors. Key trends expected to shape this market include personalized metabolic health plans, AI-based assessments of metabolic rates, cloud-supported data monitoring systems for metabolic testing, automation of testing devices, and real-time IoT-enabled body analytics.
The metabolic testing market size has grown strongly in recent years. It will grow from $0.64 billion in 2025 to $0.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rising prevalence of obesity, growing use of indirect calorimetry, increased adoption of cpets in hospitals, expanding diagnostic applications, rising awareness of metabolic disorders.
Download a free sample of the metabolic testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21219&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Primary Companies Leading the Metabolic Testing Industry
Several prominent firms occupy significant positions in the metabolic testing market. These include Becton dic*kinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc., Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc., Koninklijke Philips NV, Parvo Medics Inc., InBody Co Ltd, Schiller AG, Noraxon USA Inc., and Seca GmbH Co KG.
Recent Acquisition Enhances Metabolic Health Tracking Capabilities
In September 2024, the Finnish health technology firm Oura completed the acquisition of Veri, a company specializing in blood sugar monitoring systems based on metabolic testing. This strategic move aims to enrich Oura's health-tracking platform by incorporating metabolic health insights such as meal timing and blood glucose analysis. The integration is designed to offer users a more comprehensive understanding of their overall health through the Oura app.
View the full metabolic testing market report:
https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Innovations and Future Trends in Metabolic Testing
The market's leading companies are prioritizing the development of advanced testing instruments like metabolic analyzers to facilitate accurate, real-time metabolic analysis and support research precision. Metabolic analyzers measure an individual's metabolic rate and assess how effectively their body utilizes oxygen and converts nutrients into energy. These devices provide valuable data on calorie burn, fuel source preference (carbohydrates versus fats), and respiratory efficiency. For example, in September 2024, Japan's PHC Corporation introduced LiCellMo, a live cell metabolic analyzer tailored for cell and gene therapy research. This innovative device offers continuous, non-invasive monitoring of glucose and lactate levels in cell cultures, enabling researchers to observe metabolic activity in real time without interrupting experiments.
Comprehensive Segmentation of the Global Metabolic Testing Market
The metabolic testing market is segmented in multiple ways to provide a detailed view of its structure:
1) Equipment Type: Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, Electrocardiogram (ECG) Systems, Metabolic Carts, and Other Equipment.
2) Technology: VO2 Max Analysis, Resting Metabolic Rate (RMR) Analysis, Body Composition Analysis.
3) Application: Critical Care, Lifestyle Diseases, and Other Uses.
4) End User: Hospitals and Clinics, Sports Training Centers, and Other Users.
Further breakdown of equipment types includes:
- Body Composition Analyzers such as Dual-Energy X-ray Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), and Air Displacement Plethysmography (ADP).
- CPET Systems including treadmill or cycle ergometer-based testing, oxygen consumption measurement systems, and gas exchange measurement systems.
- ECG Systems encompassing resting ECG devices, stress ECG systems, and Holter monitors.
- Metabolic Carts divided into indirect calorimetry and open-circuit spirometry types.
- Other equipment such as continuous glucose monitoring systems, lactate testing devices, and blood pressure monitors.
This detailed segmentation highlights the diverse technologies and applications fueling growth and innovation within the metabolic testing market.
New analytical features added to our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolic Testing Market Research Explores Growth Within A $0.91 Billion Opportunity here
News-ID: 4609598 • Views: …
More Releases from The Business Research Company
Liver Diseases Therapeutics Market Analysis Highlights Growth To $24.27 Billion …
The liver diseases therapeutics sector is poised for significant expansion as advances in treatment and early detection methods continue to evolve. With rising global health challenges related to liver conditions, the market is expected to grow substantially, driven by innovations and increasing healthcare investments. Let's explore the current market valuation, key players, emerging trends, and the detailed segmentation shaping this vital industry.
Projected Market Size and Growth Outlook for Liver Diseases…
Life Sciences BPO Market Analysis Highlights Growth To $481.84 Billion By 2030 A …
The life sciences business process outsourcing (BPO) sector is on track for remarkable expansion in the coming years, driven by evolving industry demands and technological advancements. As companies seek more efficient ways to accelerate drug development, regulatory compliance, and market access, outsourcing has become a critical strategy. Let's explore the market's projected growth, key players, emerging trends, and segmentation insights shaping its future.
Projected Expansion and Size of the Life Sciences…
Metabolic Biomarker Testing Market Analysis Highlights Growth To $4.53 Billion B …
The metabolic biomarker testing market is on the verge of significant expansion, driven by advancements in healthcare technologies and growing interest in personalized medicine. As precision diagnostics become more accessible and widely adopted, this market is set to experience robust growth in the coming years. Below is an overview of the market's valuation, key players, emerging trends, and segment classifications.
Projected Market Value and Growth Rate for Metabolic Biomarker Testing …
Liver Cancer Market Study Highlights How Industry Demand Is Evolving
The liver cancer market is poised for significant expansion as advancements in diagnosis and treatment continue to emerge. With increasing awareness and technological progress, this sector is attracting considerable attention from healthcare providers and investors alike. Below, we explore the market's value projections, key players, current trends, and detailed segmentation.
Expected Market Value of the Liver Cancer Industry by 2030
The liver cancer market is predicted to experience rapid growth,…
More Releases for Metabolic
Metabolic Testing Equipment Market Size to Surge to USD 4.38 Billion by 2035 Dri …
According to Precedence Research, the global metabolic testing equipment size is projected to expand from USD 1.90 billion in 2025 to approximately USD 4.38 billion by 2035, growing at a CAGR of 8.70% from 2026 to 2035. The rising global prevalence of metabolic disorders, including obesity and diabetes, coupled with advancements in diagnostic technologies, is driving the demand for more sophisticated metabolic testing tools. These devices, including metabolic analyzers and…
Evolving Market Trends In The Metabolic Biomarker Testing Industry: Advancements …
The Metabolic Biomarker Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metabolic Biomarker Testing Market Size During the Forecast Period?
The market size for metabolic biomarker testing has seen considerable growth in the past few years. The market is predicted to…
Metabolic Testing Market - Unleash Your Body's Potential: Metabolic Testing for …
Newark, New Castle, USA - new report, titled Metabolic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Metabolic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Metabolic Testing market. The report offers an overview of the market, which…
Comprehensive Metabolic Panel Testing Market Size
The findings reviewed by GME stated that the Global Comprehensive Metabolic Panel Testing Market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Factors like the rising prevalence of chronic diseases, increasing prevalence of Covid-19 and increasing patients, technological advancements, increasing disposable income, growing geriatric population, emphasis on early diagnosis and treatment are expected to support the growth of…
Therapeutic Proteins for Metabolic Disorders Treatment Market is Driven by Incre …
Therapeutic Proteins for Metabolic Disorders Treatment Market: Introduction
Therapeutic proteins are proteins which are engineered in a laboratory for pharmaceutical use. Therapeutic proteins are used as a personalized treatment approach which supports a precisely targeted therapeutic process by making up for the deficiency of an essential protein.
Therapeutic proteins are deliberately adjusted to increase their clinical potential which is followed by enhancements derived from protein or glycol engineering, Fc fusion, or conjugation…
Inherited Metabolic Disorders Market Comprehensive Survey 2025
Global Inherited Metabolic Disorders Market: Overview
Globally, IMD affects nearly one in every 2,500 to 5,000 individuals with nearly 300 to 600 new cases found in the U.K., according to Public Health Genetics U.K. The specificity and high risk affinity of IMD varies from disorder to disorder, with some disorders like familial cylomicronemia being closely associated with Caucasians and others like porphyria being recoded largely among African Americans. These metabolic…
